Jacques Gossellin

Jacques Gossellin is an accomplished professional with extensive experience in regulatory affairs and quality assurance within the veterinary medicine sector. Currently serving as the Director and Chief Pharmaceutical Officer at Boehringer Ingelheim Animal Health France since June 2011, Jacques has successfully established and managed a comprehensive department overseeing Regulatory Affairs, Quality Assurance, Pharmacovigilance, and Veterinary Compliance, following the acquisition of Merial. Prior to this role, Jacques held various leadership positions at Pfizer Animal Health for nearly two decades, focusing on regulatory management, clinical development, and pharmacovigilance for a diverse portfolio of veterinary products. Jacques began their career as a partner in a mixed veterinary practice, complementing a strong academic background with a Doctorate in Veterinary Medicine and an MBA from ESSEC Business School.